Multipotent bone marrow-derived mesenchymal stem cells (MSCs) represent a promising cell source for autologous transplantation in many human diseases. To better realize their in vivo therapeutic potential, hypoxia preconditioning has become a novel strategy to improve the survival, migration, and an...